These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review. Kumar S; Sarma P; Kaur H; Prajapat M; Bhattacharyya A; Avti P; Sehkhar N; Kaur H; Bansal S; Mahendiratta S; Mahalmani VM; Singh H; Prakash A; Kuhad A; Medhi B Tissue Cell; 2021 Jun; 70():101497. PubMed ID: 33550034 [TBL] [Abstract][Full Text] [Related]
7. Emerging SARS-CoV-2 Genotypes Show Different Replication Patterns in Human Pulmonary and Intestinal Epithelial Cells. de Souza GAP; Le Bideau M; Boschi C; Ferreira L; Wurtz N; Devaux C; Colson P; La Scola B Viruses; 2021 Dec; 14(1):. PubMed ID: 35062227 [TBL] [Abstract][Full Text] [Related]
8. Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication. Fahnøe U; Pham LV; Fernandez-Antunez C; Costa R; Rivera-Rangel LR; Galli A; Feng S; Mikkelsen LS; Gottwein JM; Scheel TKH; Ramirez S; Bukh J Viruses; 2022 Jan; 14(2):. PubMed ID: 35215765 [TBL] [Abstract][Full Text] [Related]
9. Propagation of SARS-CoV-2 in Calu-3 Cells to Eliminate Mutations in the Furin Cleavage Site of Spike. Baczenas JJ; Andersen H; Rashid S; Yarmosh D; Puthuveetil N; Parker M; Bradford R; Florence C; Stemple KJ; Lewis MG; O'Connor SL Viruses; 2021 Dec; 13(12):. PubMed ID: 34960703 [TBL] [Abstract][Full Text] [Related]
10. Vero CCL-81 and Calu-3 Cell Lines as Alternative Hosts for Isolation and Propagation of SARS-CoV-2 Isolated in Malaysia. Rosli SNZ; Dimeng SR; Shamsuddin F; Mohd Ali MR; Muhamad Hendri NA; Suppiah J; Mohd Zain R; Thayan R; Ahmad N Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371753 [TBL] [Abstract][Full Text] [Related]
11. A cautionary perspective regarding the isolation and serial propagation of SARS-CoV-2 in Vero cells. Funnell SGP; Afrough B; Baczenas JJ; Berry N; Bewley KR; Bradford R; Florence C; Duff YL; Lewis M; Moriarty RV; Connor SLO; Osman KL; Pullan S; Rashid S; Richards KS; Stemple KJ; Knezevic I NPJ Vaccines; 2021 Jun; 6(1):83. PubMed ID: 34140522 [TBL] [Abstract][Full Text] [Related]
12. Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2. Criscuolo E; Giuliani B; Ferrari D; Ferrarese R; Diotti RA; Clementi M; Mancini N; Clementi N Viruses; 2022 Jun; 14(6):. PubMed ID: 35746703 [TBL] [Abstract][Full Text] [Related]
13. Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile. Wurtz N; Penant G; Jardot P; Duclos N; La Scola B Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):477-484. PubMed ID: 33389257 [TBL] [Abstract][Full Text] [Related]
14. In silico prediction and experimental evaluation of potential siRNAs against SARS-CoV-2 inhibition in Vero E6 cells. Sartaj Sohrab S; Aly El-Kafrawy S; Ibraheem Azhar E J King Saud Univ Sci; 2022 Jun; 34(4):102049. PubMed ID: 35493709 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium. Sims AC; Burkett SE; Yount B; Pickles RJ Virus Res; 2008 Apr; 133(1):33-44. PubMed ID: 17451829 [TBL] [Abstract][Full Text] [Related]
16. Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells. Barreto-Vieira DF; da Silva MAN; Garcia CC; Miranda MD; Matos ADR; Caetano BC; Resende PC; Motta FC; Siqueira MM; Girard-Dias W; Archanjo BS; Barth OM Mem Inst Oswaldo Cruz; 2021; 116():e200443. PubMed ID: 33566951 [TBL] [Abstract][Full Text] [Related]
18. Atorvastatin Effectively Inhibits Ancestral and Two Emerging Variants of SARS-CoV-2 Zapata-Cardona MI; Flórez-Álvarez L; Zapata-Builes W; Guerra-Sandoval AL; Guerra-Almonacid CM; Hincapié-García J; Rugeles MT; Hernandez JC Front Microbiol; 2022; 13():721103. PubMed ID: 35369500 [TBL] [Abstract][Full Text] [Related]
19. Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis. Wang L; Guzman M; Muñoz-Santos D; Honrubia JM; Ripoll-Gomez J; Delgado R; Sola I; Enjuanes L; Zuñiga S Front Cell Infect Microbiol; 2023; 13():1268227. PubMed ID: 37942479 [TBL] [Abstract][Full Text] [Related]
20. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. Ogando NS; Dalebout TJ; Zevenhoven-Dobbe JC; Limpens RWAL; van der Meer Y; Caly L; Druce J; de Vries JJC; Kikkert M; Bárcena M; Sidorov I; Snijder EJ J Gen Virol; 2020 Sep; 101(9):925-940. PubMed ID: 32568027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]